| Maxim Healthcare Services | |
| 933 Mayfair Rd Suite 201, Wauwatosa, Wisconsin 53226 | |
| (414) 475-9330 | |
| Not Available |
| Name | Maxim Healthcare Services |
|---|---|
| Location | 933 Mayfair Rd Suite 201, Wauwatosa, Wisconsin |
| Certified By | Medicare |
| Services Offered | Nursing Care Home Health Aide |
| Medicare ID | 527287 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 53105, 53224 |
| NPI Number | 1912960832 |
| Organization Name | MAXIM HEALTHCARE SERVICES, INC. |
| Address | 933 N Mayfair Rd, Suite 201, Wauwatosa, WI 53226 |
| Phone Number | 414-475-9330 |
News Archive
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 - nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
A potential correlation between pre-labor cesarean delivery (PLCD) and acute lymphoblastic leukemia (ALL) could offer new targets for cancer prevention research, according to new research from the Masonic Cancer Center, University of Minnesota.
Pfizer Inc. announced today the discontinuation of A4021016 (also known as ADVIGO 1016), a Phase 3 trial examining the effects of investigational compound figitumumab (CP-751,871) as first-line treatment in patients with advanced non-adenocarcinoma non-small cell lung cancer (NSCLC) due to the study meeting predefined boundaries for early termination.
As with any new research regarding potential health effects associated with bisphenol A (BPA), the North American Metal Packaging Alliance, Inc. (NAMPA) takes seriously the findings of this latest study published in the Journal of the American Medical Association (JAMA).
This coverage decision ensures that an estimated 30 percent of the 42 million people who participate in Medicare will be able to undertake physician-supervised weight-loss programs.
› Verified 3 days ago
| Quality Rating: | Not Available* |
| * The number of patient episodes for this measure is too small to report. | |
News Archive
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 - nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
A potential correlation between pre-labor cesarean delivery (PLCD) and acute lymphoblastic leukemia (ALL) could offer new targets for cancer prevention research, according to new research from the Masonic Cancer Center, University of Minnesota.
Pfizer Inc. announced today the discontinuation of A4021016 (also known as ADVIGO 1016), a Phase 3 trial examining the effects of investigational compound figitumumab (CP-751,871) as first-line treatment in patients with advanced non-adenocarcinoma non-small cell lung cancer (NSCLC) due to the study meeting predefined boundaries for early termination.
As with any new research regarding potential health effects associated with bisphenol A (BPA), the North American Metal Packaging Alliance, Inc. (NAMPA) takes seriously the findings of this latest study published in the Journal of the American Medical Association (JAMA).
This coverage decision ensures that an estimated 30 percent of the 42 million people who participate in Medicare will be able to undertake physician-supervised weight-loss programs.
› Verified 3 days ago
News Archive
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 - nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
A potential correlation between pre-labor cesarean delivery (PLCD) and acute lymphoblastic leukemia (ALL) could offer new targets for cancer prevention research, according to new research from the Masonic Cancer Center, University of Minnesota.
Pfizer Inc. announced today the discontinuation of A4021016 (also known as ADVIGO 1016), a Phase 3 trial examining the effects of investigational compound figitumumab (CP-751,871) as first-line treatment in patients with advanced non-adenocarcinoma non-small cell lung cancer (NSCLC) due to the study meeting predefined boundaries for early termination.
As with any new research regarding potential health effects associated with bisphenol A (BPA), the North American Metal Packaging Alliance, Inc. (NAMPA) takes seriously the findings of this latest study published in the Journal of the American Medical Association (JAMA).
This coverage decision ensures that an estimated 30 percent of the 42 million people who participate in Medicare will be able to undertake physician-supervised weight-loss programs.
› Verified 3 days ago
Anew Home Hlth Care Location: 7425 Harwood Ave, Wauwatosa, Wisconsin 53213 Ratings: NA Phone: (414) 475-7788 | |
St Camillus Home Health Agency Location: 10101 W Wisconsin Ave, Wauwatosa, Wisconsin 53226 Ratings: Phone: (414) 258-2418 | |
Preferred Home Health Services Location: 811 N Hawley Rd, Suite 102, Wauwatosa, Wisconsin 53213 Ratings: NA Phone: (414) 774-3901 | |
Maxim Healthcare Services Location: 933 Mayfair Rd Suite 201, Wauwatosa, Wisconsin 53226 Ratings: NA Phone: (414) 475-9330 |